Status:
RECRUITING
Microparticles in Obstructive Sleep Apnea
Lead Sponsor:
University Hospital, Angers
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
Obstructive sleep apnea (OSA) is independently associated with cardiovascular diseases, including myocardial infarction and stroke. OSA may promote atherosclerosis risk factors such as hypertension, d...
Detailed Description
MPs are small plasma membrane vesicles that can be released by a variety of vascular or blood cells and that contain membrane and cytosolic elements. Case-control studies have shown that platelet-, en...
Eligibility Criteria
Inclusion
- diagnosis of coronary artery disease or cerebrovascular disease
- diagnosis of moderate-to-severe OSA
Exclusion
- pregnancy
- previously treated OSA
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 20 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03438149
Start Date
February 20 2018
End Date
February 20 2026
Last Update
January 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire du Sommeil, Département de Pneumologie, CHU d'Angers
Angers, France, 49100